Novartis said on Sunday that it is voluntarily recalling certain lots of over-the-counter products because they might contain broken or stray tablets from other products [1]. The recall comes following consumer complaints of chipped and broken pills, and inconsistent bottle packaging line clearance practices (meaning cleaning and clearance operations that are performed when a product or strength change occurs during medicine packaging) that may have possibly resulted in mixed tablets.